Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.

Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A, Easton D, Lakhani SR.

Breast Cancer Res. 2007;9(1):R4.

PMID: 17217540 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.

J Pathol. 2006 Mar;208(4):495-506.

PMID: 16429394 [PubMed - indexed for MEDLINE]

Related Articles

Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes.

Jones C, Ford E, Gillett C, Ryder K, Merrett S, Reis-Filho JS, Fulford LG, Hanby A, Lakhani SR.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):5988-97.

PMID: 15447982 [PubMed - indexed for MEDLINE]

Related Articles

Cytokeratin profiles of male breast cancers.

Ciocca V, Bombonati A, Gatalica Z, Di Pasquale M, Milos A, Ruiz-Orrico A, Dreher D, Folch N, Monzon F, Santeusanio G, Perou CM, Bernard PS, Palazzo JP.

Histopathology. 2006 Oct;49(4):365-70.

PMID: 16978199 [PubMed - indexed for MEDLINE]

Related Articles

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

Jumppanen M, Gruvberger-Saal S, Kauraniemi P, Tanner M, Bendahl PO, Lundin M, Krogh M, Kataja P, Borg A, Fernö M, Isola J.

Breast Cancer Res. 2007;9(1):R16.

PMID: 17263897 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

The influence of basal phenotype on the metastatic pattern of breast cancer.

Luck AA, Evans AJ, Green AR, Rakha EA, Paish C, Ellis IO.

Clin Oncol (R Coll Radiol). 2008 Feb;20(1):40-5. Epub 2007 Nov 5.

PMID: 17981444 [PubMed - indexed for MEDLINE]

Related Articles

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.

Hum Pathol. 2006 Sep;37(9):1217-26. Epub 2006 Jul 18.

PMID: 16938528 [PubMed - indexed for MEDLINE]

Related Articles

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, Eusebi V, Lakhani SR.

Br J Cancer. 2001 Aug 3;85(3):422-7.

PMID: 11487275 [PubMed - indexed for MEDLINE]

Related Articles

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

Dabbs DJ, Chivukula M, Carter G, Bhargava R.

Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.

PMID: 16941011 [PubMed - indexed for MEDLINE]

Related Articles

Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific type.

Hamilton LJ, Evans AJ, Pinder SE, James JJ, Gutteridge E, Cornford EJ, Burrell HC, Chan SY, Robertson JF, Cheung KL.

Clin Oncol (R Coll Radiol). 2004 Apr;16(2):119-24.

PMID: 15074735 [PubMed - indexed for MEDLINE]

Related Articles

Basal-like breast carcinomas: clinical outcome and response to chemotherapy.

Banerjee S, Reis-Filho JS, Ashley S, Steele D, Ashworth A, Lakhani SR, Smith IE.

J Clin Pathol. 2006 Jul;59(7):729-35. Epub 2006 Mar 23.

PMID: 16556664 [PubMed - indexed for MEDLINE]

Related Articles

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.

Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A.

Histopathology. 2006 Jul;49(1):22-34.

PMID: 16842243 [PubMed - indexed for MEDLINE]

Related Articles

Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma.

Silver SA, Tavassoli FA.

Histopathology. 2000 Jun;36(6):505-14.

PMID: 10849092 [PubMed - indexed for MEDLINE]

Related Articles

Epidermal growth factor receptor (EGFR) as a prognostic marker: an immunohistochemical study on 315 consecutive breast carcinoma patients.

Aziz SA, Pervez S, Khan S, Kayani N, Rahbar MH.

J Pak Med Assoc. 2002 Mar;52(3):104-10.

PMID: 12071064 [PubMed - indexed for MEDLINE]

Related Articles

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

Rakha EA, El-Rehim DA, Paish C, Green AR, Lee AH, Robertson JF, Blamey RW, Macmillan D, Ellis IO.

Eur J Cancer. 2006 Dec;42(18):3149-56. Epub 2006 Oct 19.

PMID: 17055256 [PubMed - indexed for MEDLINE]

Related Articles

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.

Reis-Filho JS, Steele D, Di Palma S, Jones RL, Savage K, James M, Milanezi F, Schmitt FC, Ashworth A.

Mod Pathol. 2006 Feb;19(2):307-19.

PMID: 16424897 [PubMed - indexed for MEDLINE]

Related Articles

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Hardisson D, Calero F, Benitez J, Palacios J.

Clin Cancer Res. 2006 Mar 1;12(5):1533-9.

PMID: 16533778 [PubMed - indexed for MEDLINE]

Related Articles

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Fadare O, Wang SA, Hileeto D.

Hum Pathol. 2008 Mar;39(3):331-6.

PMID: 18261623 [PubMed - indexed for MEDLINE]

Related Articles

Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.

Liu H, Fan Q, Zhang Z, Li X, Yu H, Meng F.

Hum Pathol. 2008 Feb;39(2):167-74. Epub 2007 Nov 28.

PMID: 18045647 [PubMed - indexed for MEDLINE]

Related Articles

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO.

Eur J Cancer. 2008 Jan;44(1):73-83. Epub 2007 Nov 26.

PMID: 18035533 [PubMed - indexed for MEDLINE]

Related Articles